Susi Roger E. 4
4 · IRADIMED CORP · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
IRADIMED (IRMD) 10% Owner Roger E. Susi Sells Shares
What Happened
Roger E. Susi, reported as a 10% owner of IRADIMED CORP (IRMD), sold a total of 7,500 shares in open-market transactions on March 6, 2026. The sales were reported as: 6,300 shares at a weighted-average price of $98.25 (proceeds $618,975) and 1,200 shares at a weighted-average price of $99.12 (proceeds $118,944), for combined proceeds of approximately $737,919. These were sales (not purchases), which are often routine divestitures rather than a bullish signal.
Key Details
- Transaction date: March 6, 2026; Form 4 filed March 9, 2026 (filed within the typical two-business-day Form 4 window).
- Shares sold: 6,300 @ $98.25 (weighted avg) and 1,200 @ $99.12 (weighted avg); total shares = 7,500; total proceeds ≈ $737,919.
- Footnotes:
- F1: Sales were made under a Rule 10b5-1 trading plan adopted Nov 5, 2025.
- F2/F3: Each sale block was executed in multiple trades across small price ranges (first block ranged $98.00–$99.00; second block ranged $99.01–$99.22); reported prices are weighted averages and more details can be provided on request.
- F4: The reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
Context
- 10b5-1 plan: Sales under an existing 10b5-1 plan are pre-scheduled trades and are typically considered routine — they do not necessarily reflect the insider’s current view of the company.
- 10% owner note: As a 10% owner, Susi is a large shareholder; such holders differ from executive officers but are still subject to Section 16 reporting.
- Interpretation: Sales provide liquidity to the insider; purchases are generally more informative for bullish sentiment. This report is factual disclosure of the trades and does not indicate motive.
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
Susi Roger E.
DirectorCEO, President, Chairman10% Owner
Transactions
- Sale
Common Stock
[F1][F2]2026-03-06$98.25/sh−6,300$618,975→ 2,256,200 total(indirect: By Trust) - Sale
Common Stock
[F1][F3]2026-03-06$99.12/sh−1,200$118,944→ 2,255,000 total(indirect: By Trust)
Holdings
- 162,950(indirect: By Trust)
Common Stock
- 2,062,500(indirect: By Trust)
Common Stock
[F4]
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $98.00 to $99.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $99.01 to $99.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Roger E. Susi|2026-03-09